Guillain-barré Syndrome In The Elderly: Clinical, Electrophysiological, Therapeutic And Outcome Features

dc.creatorFranca Jr. M.C.
dc.creatorDeus-Silva L.
dc.creatorDe Castro R.
dc.creatorGaribaldi S.G.
dc.creatorPfeilsticker B.H.M.
dc.creatorNucci A.
dc.creatorMarques Jr. J.F.C.
dc.date2005
dc.date2015-06-26T14:09:15Z
dc.date2015-11-26T14:09:06Z
dc.date2015-06-26T14:09:15Z
dc.date2015-11-26T14:09:06Z
dc.date.accessioned2018-03-28T21:09:39Z
dc.date.available2018-03-28T21:09:39Z
dc.identifier
dc.identifierArquivos De Neuro-psiquiatria. , v. 63, n. 3 B, p. 772 - 775, 2005.
dc.identifier0004282X
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-27144508863&partnerID=40&md5=d5bdc39fde447d41fcce5e35a5c7c74a
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/93754
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/93754
dc.identifier2-s2.0-27144508863
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1241154
dc.descriptionThere are few papers devoted to geriatric Guillain-Barré (GBS) and many related issues remain unanswered. Objective: To describe clinical, electrophysiological and therapeutic features in this age. Method: Clinico-epidemiological data and therapy of GBS patients older than 60 years were reviewed. Hughes scores were used to quantify neurological deficit and define outcome. Results: Among 18 patients (mean age 64.8 years), 9 had evident prodrome and 80% noticed initially sensory-motor deficit. Demyelinating GBS was found in 8 and axonal in 6 subjects. There was one Miller-Fisher and 3 unclassified cases. Plasmapheresis (PFX) was single therapy in 12 patients and intravenous immunoglobulin (IVIg) in 2. Disability scores just before therapy were similar in both groups, so as short and long term outcome. Conclusion: Axonal GBS seems to be more frequent in the elderly and this may have prognostic implications. PFX and IVIg were suitable options, but complications were noticed with PFX. Prospective studies are needed to better understand and manage GBS in the elderly.
dc.description63
dc.description3 B
dc.description772
dc.description775
dc.descriptionKuwabara, S., Guillain-Barré syndrome: Epidemiology, pathophysiology and management (2004) Drugs, 64, pp. 597-610
dc.descriptionHughes, R.A.C., Rees, J.H., Clinical and epidemiological features of Guillain-Barré syndrome (1997) J Infect Dis, 176 (SUPPL. 2), pp. S92-S98
dc.descriptionHartung, H.P., Willison, H.J., Kieseier, B.C., Acute immunoinflammatory neuropathy: Update on Guillain-Barré syndrome (2002) Curr Opin Neurol, 15, pp. 571-577
dc.descriptionEfficiency of plasma exchange in Guillain-Barré syndrome: Role of replacement fluids (1987) Ann Neurol, 22, pp. 753-761
dc.descriptionGreenwood, R.J., Newsom Davis, J.M., Hughes, R.A.C., Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy (1984) Lancet, 1, pp. 877-879
dc.descriptionOsterman, P.O., Lundemo, G., Pirskanen, R., Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy (1984) Lancet, 2, pp. 1296-1299
dc.descriptionPlasmapheresis and acute Guillain-Barré syndrome (1985) Neurology, 35, pp. 1096-1104
dc.descriptionPlasma exchange in Guillain-Barré syndrome: One-year follow-up (1992) Ann Neurol, 32, pp. 94-97
dc.descriptionVan Der Meché, F.G.A., Schmitz, P.I.M., A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome (1992) N Engl J Med, 326, pp. 1123-1129
dc.descriptionRandomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome (1997) Lancet, 349, pp. 225-230
dc.descriptionSridharan, G.V., Tallis, R.C., Gautam, P.C., Guillain-Barré syndrome in the elderly: A retrospective comparative study (1993) Gerontology, 39, pp. 170-175
dc.descriptionWinner, S.J., Evans, J.G., Guillain-Barré syndrome in Oxfordshire: Clinical features in relation to age (1993) Age Ageing, 22, pp. 164-170
dc.descriptionYamashita, S., Morinaga, T., Matsumoto, K., Sakamoto, T., Kaku, N., Matsukura, S., Severe Guillain-Barré syndrome in aged patients: The effect of plasmapheresis (1992) Intern Med, 31, pp. 1313-1316
dc.descriptionRana, S.S., Rana, S., Intravenous immunoglobulins versus plasmapheresis in older patients with Guillain-Barré syndrome (1999) J Am Geriatr Soc, 47, pp. 1387-1388
dc.descriptionAsbury, A.K., Cornblath, D.R., Assessment of current diagnostic criteria for Guillain-Barré syndrome (1990) Ann Neurol, 27 (SUPPL.), pp. S21-S24
dc.descriptionSeneviratne, U., Guillain-Barré syndrome (2000) Postgrad Med J, 76, pp. 774-782
dc.descriptionHughes, R.A.C., Newsom-Davis, J.M., Perkin, G.D., Pierce, J.M., Controlled trial of prednisolone in acute polyneuropathy (1978) Lancet, 2, pp. 750-753
dc.descriptionRocha, M.S.G., Brucki, S.M.D., Carvalho, A.A.S., Lima, U.W.P., Epidemiologic features of Guillain-Barre syndrome in São Paulo, Brazil (2004) Arq Neuropsiquiatr, 62, pp. 33-37
dc.descriptionVan Der Meche, F.G., Visser, L.H., Jacobs, B.C., Endtz, H.P., Meulstee, J., Van Doom, P.A., Guillain-Barré syndrome: Multifactorial mechanisms versus defined subgroups (1997) J Infect Dis, 176 (SUPPL. 2), pp. S99-S102
dc.descriptionSheth, R.D., Riggs, J.E., Hobbs, G.R., Gutmann, L., Age and Guillain-Barré syndrome severity (1996) Muscle Nerve, 19, pp. 375-377
dc.descriptionDias-Tosta, E., Kuckelhaus, C.S., Guillain-Barre syndrome in a population less than 15 years old in Brazil (2002) Arq Neuropsiquiatr, 60, pp. 367-373
dc.languageen
dc.publisher
dc.relationArquivos de Neuro-Psiquiatria
dc.rightsaberto
dc.sourceScopus
dc.titleGuillain-barré Syndrome In The Elderly: Clinical, Electrophysiological, Therapeutic And Outcome Features
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución